2024-10-02 PILL-Rx Vaccinations Q&A: Ann Philbrick

views

PILL-Rx October 2024 Session: Immunization Check-in & Updates!

In this session of PILL-Rx, Dr. Ann Philbrick will provide a brief presentation with Vaccine Updates this 2024 season, and we will then have an open forum for Community Pharmacists in Minnesota to share their plans, ideas, questions and concerns about the upcoming season. If you would like to submit any immunization questions or topics, please email pillrx@umn.edu.

Presented by: Ann Philbrick, PharmD, FCCP, BCPS, BCACP. Dr. Ann Philbrick is an Associate Professor at the University of Minnesota College of Pharmacy in the Department of Pharmaceutical Care and Health Systems and the University of Minnesota Medical School in the Department of Family Medicine and Community Health). She graduated with a doctorate of pharmacy from the University of Nebraska Medical Center and went on to complete a PGY1 And PGY2 residency in Ambulatory Care at the University of Iowa Hospitals and Clinics. She currently practices at Bethesda Family Medicine Clinic, the longitudinal clinic site of the University of Minnesota Woodwinds Family Medicine Residency Program.

This session occurred virtually on Wednesday October 2, 2024 from 12:15-1pm.

Attendance at the session, or review of the session recording, will count for 0.5 hours towards your biannual 1-hour immunization CE requirement. To receive CE credit, complete the CE evaluation at this link: https://umn.qualtrics.com/jfe/form/SV_cOL0PskTmDpXzFk

Accreditation and Conflict of Interest Statement: As a Jointly Accredited Provider of Interprofessional Continuing Education Credit, the National Center for Interprofessional Practice and Education Office of Interprofessional Continuing Professional Development (OICPD) complies with the ACCME and Joint Accreditors’ Standards for Integrity and Independence in Accredited Continuing Education. The National Center has a conflict of interest policy that requires all individuals involved in the development, planning, implementation, peer review and/or evaluation of an activity to disclose any financial relationships with ineligible companies. The National Center performs a thorough review of the content of the accredited activity to ensure that any financial relationships have no influence on the content of accredited activities. All potential conflicts of interest that arise based on these financial relationships are mitigated prior to the accredited activity.

All individuals involved in the development of this learning activity were required to disclose any financial relationships with ineligible companies and any potential conflicts of interest have been mitigated.

Sarah Westberg - Consultant - Astellas Pharma

Practice Innovation Learning Lab (PILL-Rx)

Tags